We use a session cookie and first-party analytics to run this site — no third-party trackers, no ads. Details in our Privacy Policy.
RESEARCH From the Research Desk — The sub-₹100 crore acquisition market, sized. Read it →
Solvent wind-down · IBC Section 59

Maco Pharma India Transfusion Solutions Private Limited

U24230DL2013FTC258426 · Company
Under Liquidation
Liquidation outcome · IBC s.59
Realisation of assets
Amount due to creditors
Amount paid to creditors
Liquidation expenses
Surplus to members
Commenced
27 Nov 2023
Dissolved
Solvent voluntary liquidation under IBC Section 59 — a healthy company choosing to wind up. Creditors are paid in full and costs met before any surplus returns to members; there is no haircut or acquirer.
Company · MCA master
MCA status
Under Liquidation
Company class
Private
Category
Company limited by shares
Sub-category
subsidiary of company incorporated outside India
Listing
Unlisted
Incorporated
26 Sep 2013
Authorised capital
₹18.00 Cr
Paid-up capital
₹18.00 Cr
ROC
ROC Delhi
Industry
Manufacturing (Metals and Chemicals, and products thereof)
PIN
110085
Registered office
Office unit no. 310, RG mall,Sector 9, Rohini,Delhi,North West Delhi,Delhi,110085-India
Liquidator
ICAI IIIPI
IBBI/IPA-001/IP-P-02416/2021-2022/13622
View full RP profile →

Full voluntary-liquidation records — realisation, payout and surplus across every quarter — are part of the Full Investor Desk.

Apply for access →

See plans →

← All voluntary liquidations